Friday September 9, 2011 the Drug Safety and Risk Management Committee will meet to discuss the issues involving Bisphosphonates for the treatment and prevention of osteoporosis.
The Food and Drug Administration released the background materials for this meeting on September 7, 2011 and the issues for committee consideration are:
I said (to myself), "I will complete this essay by the end of the year." (Repeat for effect!) You see, I had been trying to to describe... Read more »
Having reached middle age, at times I hear the ticking of an internal clock. It’s not the clock that has to do with having children.... Read more »
There's no doubt about it, children with ADHD are often unorganized and lack time management skills. They may have trouble sequencing... Read more »
Last week, I shared some findings from a 2005 report entitled “The Science of Aging Gracefully: Scientists and the Public talk about... Read more »
I believe good health is every U.S. citizen's right. Of course, no one can guarantee that we will not contract a disease or encounter an... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
